Massimo Morfini
Milan, 21121, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life.
Journal: Journal of clinical medicine
Published: July 30, 2024
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients.
Journal: Medicina (Kaunas, Lithuania)
Published: October 16, 2023
Managing Relevant Clinical Conditions of Hemophilia A/B Patients.
Journal: Hematology reports
Published: February 09, 2023
Bioequivalence of recombinant factor VIII products: a position paper from the Italian Association of Hemophilia Centers.
Journal: Blood transfusion = Trasfusione del sangue
Published: October 06, 2022
Modulation of factor VIII pharmacokinetics by genetic components in factor VIII receptors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: August 11, 2022
Combination of CLEC4M rs868875 G-Carriership and ABO O Genotypes May Predict Faster Decay of FVIII Infused in Hemophilia A Patients.
Journal: Journal of clinical medicine
Published: November 26, 2021
The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A.
Journal: Thrombosis and haemostasis
Published: August 18, 2021
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 01, 2021
Recent Advances in the Treatment of Hemophilia: A Review.
Journal: Biologics : targets & therapy
Published: February 02, 2021
A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects.
Journal: Thrombosis and haemostasis
Published: January 27, 2021
Pharmacokinetic characteristics of the triple inactivated plasma-derived Kedrion FIX concentrate: data from the KB037 clinical trial.
Journal: Data in brief
Published: August 03, 2020
Joint replacement for the management of haemophilic arthropathy in patients with inhibitors: A long-term experience at a single Haemophilia centre.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: August 02, 2020
Last Updated: 09/26/2026